FDA News Digest September 9, 2002 ________________________________________________________ FDA to Merge Review of Drugs and Biological Pharmaceuticals FDA has announced plans to transfer responsibility for review of new biological pharmaceuticals into its Center for Drug Evaluation and Research. The plan will free the agency's biologics center to concentrate on areas such as vaccines and blood safety. http://www.fda.gov/bbs/topics/NEWS/2002/NEW00834.html _________________________________________________________________ New Chief of FDA Field Operations Named John M. Taylor has been appointed FDA senior associate commissioner for regulatory affairs, with responsibilities that include overseeing the agency's field force. He replaces Dennis Baker, who has held the position since 1999. http://www.fda.gov/bbs/topics/NEWS/2002/NEW00833.html _________________________________________________________________ Panel Will Discuss Safety of Acetaminophen, Other OTC Pain Relievers FDA's Nonprescription Drugs Advisory Committee will meet Sept. 19 and 20 in Silver Spring, Md., to discuss safety issues related to use of acetaminophen in over-the-counter (OTC) and prescription drugs, and of aspirin and other OTC nonsteroidal anti-inflammatory drugs. The meeting is open to the public and doesn't require advance registration. http://www.fda.gov/OHRMS/DOCKETS/98fr/082002c.htm _________________________________________________________________ Thanks for subscribing to the FDA News Digest. Our next posting will be September 16. To leave this list at any time, send an e-mail to LISTSERV@LIST.NIH.GOV In the body of the message, write SIGNOFF FDA-NEWSDIGEST-L
